1631. Background Incidence Rates of Health Outcomes Relevant to Vaccine Monitoring in Lyme Disease Endemic and Non-endemic US Regions using Administrative Claims Data

BACKGROUND: A 6-valent vaccine (VLA15) is being tested in clinical trials for the prevention of Lyme disease caused by Borrelia burgdorferi sensu lato strains expressing OspA serotypes 1-6. Background incidence rates (IRs) of health outcomes in Lyme disease endemic and non-endemic regions of the US...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyfus, Jill, Munnangi, Swapna, DeKoven, Mitchell, Bengtsson, Camilla, Correia, Barbara, Figueiredo, Rejane, Galvin, Sarah, Stark, James H, Zawora, Michele, Riddle, Mark, Maguire, Jason, Jiang, Qin, Turrado, Juan Naredo, Svanström, Henrik, Bailey, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677686/
http://dx.doi.org/10.1093/ofid/ofad500.1465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677686/
http://dx.doi.org/10.1093/ofid/ofad500.1465

Ejemplares similares